Under the terms of the deal, Bedford, Mass.-based Stoke (STOK) will retain exclusive rights for the treatment called zorevunersen in the U.S., Canada and Mexico, while Cambridge, Mass.-based Biogen ...

Biotechnology specialist Amgen (NASDAQ:AMGN) reported fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 4, that topped analysts' consensus estimates. Analysts estimated Q4 adjusted EPS ...

Verification of processor itself and related sub-systems with different models is not a question of preference but a need based on different precision granularity expected from the models. For example ...

Thousand Oaks, CA-based Amgen is one of the biggest biotech companies in the world, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation ...

As Sandoz gears up to launch one of the most anticipated biosimilars of the year, the company could face near-term competition thanks to a new agreement between Amgen and Celltrion. Late last week ...

He describes it as a “harrowing experience” and asked us to share it with readers “to raise awareness of this potentially very serious form of identity theft in the hope that it may protect ...

Celltrion Inc.’s biosimilar versions of Amgen Inc.’s blockbuster bone-strengthening drugs Prolia and Xgeva are blocked in the US until June 1 as part of a settlement agreement, according to a filing ...

Leveraging single-use technology, the new Amgen North Carolina facility will incorporate traditional stainless steel-fed batch plant processes. Credit: Amgen Inc. Amgen has inaugurated its new drug ...

An official ribbon-cutting ceremony took place Friday for Amgen's new manufacturing plant in Holly Springs. It's at the CaMP Helix Innovation Park. The celebration also included a ground-breaking ...

The global company says it will eventually employ 700 at its Wake County factories. STORY HIGHLIGHTS Amgen completed a $550 million facility in Holly Springs. Company has started construction on a ...